Vetoquinol SA (VETO.PA) Quote| Reuters.com
Edition:
United States

Vetoquinol SA (VETO.PA)

VETO.PA on Paris Stock Exchange

36.38EUR
27 Jun 2016
Change (% chg)

-- (--)
Prev Close
€36.38
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,243
52-wk High
€42.00
52-wk Low
€33.04

VETO.PA

Chart for VETO.PA

About

Vetoquinol SA is a France-based company that specializes in the research, development, manufacture, marketing and sale of veterinary drugs and products. The Company’s product portfolio is divided between livestock, such as cattle and pigs, and companion animals, including dogs and cats. Vetoquinol SA’s offering includes... (more)

Overall

Beta: 0.48
Market Cap(Mil.): €421.81
Shares Outstanding(Mil.): 11.88
Dividend: 0.41
Yield (%): 1.15

Financials

  VETO.PA Industry Sector
P/E (TTM): 17.44 32.69 34.11
EPS (TTM): 2.04 -- --
ROI: 7.40 15.00 14.23
ROE: 8.66 16.08 15.46

BRIEF-Vetoquinol Q1 sales up at 85.8 mln euros

* Q1 2016 sales are 85.8 million euros, representing organic growth of 7.7 pct Source text for Eikon: Further company coverage: ($1 = 0.8794 euros) (Gdynia Newsroom)

Apr 19 2016

BRIEF-Vetoquinol FY net income slightly drops to 24.2 mln euros

* FY group net income amounted to EUR 24.2 million ($27.20 million), down slightly by EUR 1.6 million

Mar 21 2016

BRIEF-Vetoquinol Q4 sales rise 8.5 pct to 90.8 mln euros

* Reports Q4 sales in 8.5 pct growth to 90.8 million euros ($98.28 million), reflecting 6.2 pct organic growth

Jan 21 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$300.00
Provider : Sadif Analytics Prime
$25.00
Provider : Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.